Objective: To determine factors influencing survival and prognosis of HPV-related and non-related oropharyngeal cancer.
Methods: Subjects were determined from the three hospitals in Anhui province of China between 2015 and 2020. Paraffin-embedded specimens from participants’ tissues were analyzed, and the subjects were classified as P16+ and P16– cases using immunohistochemical staining for P16 protein.
Results: 426 patients with oropharyngeal cancer were recruited in this study, 108 cases were found to be P16+. The subjects were treated with the three regimens: surgery/radiotherapy/chemotherapy (SRCT), radiotherapy/chemotherapy (RCT), surgery/chemotherapy (SCT). There were no statistically significant differences in the survival rates within the P16+ or P16– groups between the three treatment regimens (P > 0.05). The 1-, 3-, and 5-year survival rates for P16+ and P16– groups were statistically different (P < 0.05). Multivariate analysis showed that age, physical health status, smoking, and alcohol abuse were independent risk factors affecting the prognosis of P16+ cases, while pathological grading and TNM staging were independent risk factors affecting the P16– cases.
Conclusion: The etiology, pathogenesis, survival status, and prognostic factors of HPV-related oropharyngeal cancer are very different from those of traditional oropharyngeal cancer. Thus, HPV-related oropharyngeal cancer could be classified as a separate type of disease. This distinction could be of great significance for treatment, prevention, and prognostication of oropharyngeal cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.